TAVI with the SAPIEN family is an established and efficient procedure

Sponsored by Edwards Lifesciences

Chairpersons: I. Al Rashdan, M. Tuzcu

Learning Objectives

  • To learn from the latest evidence in the field of TAVI
  • To understand what the intermediate risk indication means for your patient selection
  • To learn how the TAVI procedure can be further streamlined with new generation delivery systems and valves and how the efficiencies can be leveraged